Professor Ralph Martins has dedicated the last 35 years to Alzheimer’s Disease (AD) research. He is well-known and highly respected internationally as a prominent researcher in the field. His insight into this devastating disease has led to a number of ground breaking discoveries including the pioneering discovery of Beta-amyloid and its precursor the amyloid precursor protein (APP), an important protein found in the brains of Alzheimer’s patients now universally acknowledged as being fundamental to the pathology of this disease. His identification of oxidative stress in the Alzheimer brain has also been described as a significant landmark in the history of the disease. Professor Martins and his team have been at the forefront globally in developing non-invasive and cost-effective early diagnostics for pre-clinical AD. They are also progressing a highly innovative program of therapeutic strategies and preventative interventions in pre-clinical AD.